ATE556062T1 - 3,4-dihydrochinazolinderivate - Google Patents

3,4-dihydrochinazolinderivate

Info

Publication number
ATE556062T1
ATE556062T1 AT08753326T AT08753326T ATE556062T1 AT E556062 T1 ATE556062 T1 AT E556062T1 AT 08753326 T AT08753326 T AT 08753326T AT 08753326 T AT08753326 T AT 08753326T AT E556062 T1 ATE556062 T1 AT E556062T1
Authority
AT
Austria
Prior art keywords
dihydroquinazoline derivatives
dihydroquinazoline
derivatives
preparing
formula
Prior art date
Application number
AT08753326T
Other languages
English (en)
Inventor
Jae Yeol Lee
Dong Joon Choo
Young Deuk Kim
Chun Rim Oh
Original Assignee
Dongwoo Syntech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dongwoo Syntech Co Ltd filed Critical Dongwoo Syntech Co Ltd
Application granted granted Critical
Publication of ATE556062T1 publication Critical patent/ATE556062T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT08753326T 2007-05-08 2008-05-06 3,4-dihydrochinazolinderivate ATE556062T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20070044655 2007-05-08
KR1020070087583A KR100902145B1 (ko) 2007-05-08 2007-08-30 3,4-디히드로퀴나졸린 유도체 및 그를 포함하는 항암제조성물
PCT/KR2008/002529 WO2008136631A1 (en) 2007-05-08 2008-05-06 3,4-dihydroquinazoline derivatives

Publications (1)

Publication Number Publication Date
ATE556062T1 true ATE556062T1 (de) 2012-05-15

Family

ID=40286298

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08753326T ATE556062T1 (de) 2007-05-08 2008-05-06 3,4-dihydrochinazolinderivate

Country Status (7)

Country Link
US (1) US8168646B2 (de)
EP (1) EP2142518B1 (de)
JP (1) JP5330377B2 (de)
KR (1) KR100902145B1 (de)
CN (1) CN101679312B (de)
AT (1) ATE556062T1 (de)
WO (1) WO2008136631A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101345471B1 (ko) * 2011-03-16 2014-01-23 동우신테크 주식회사 3,4-디히드로퀴나졸린 유도체의 제조방법 및 이를 위한 중간체
KR101473453B1 (ko) * 2012-07-31 2014-12-19 경희대학교 산학협력단 신규한 화합물, 이의 제조방법 및 이를 포함하는 약제학적 조성물
KR101693326B1 (ko) 2014-05-23 2017-01-05 경희대학교 산학협력단 3,4-디히드로퀴나졸린 유도체 및 그를 포함하는 복합제
CN110003121A (zh) * 2019-04-30 2019-07-12 郑州大学 一种3,4-二氢喹唑啉衍生物及其制备方法、应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE507210T1 (de) 2002-03-07 2011-05-15 X Ceptor Therapeutics Inc Chinazolinon modulatoren von nukleinrezeptoren
KR100610731B1 (ko) 2004-02-24 2006-08-09 한국과학기술연구원 Ｔ-형 칼슘 채널 차단제로서 유용한 ３,４-디히드로퀴나졸린유도체 및 그의 제조 방법

Also Published As

Publication number Publication date
CN101679312B (zh) 2012-08-08
EP2142518A1 (de) 2010-01-13
US8168646B2 (en) 2012-05-01
EP2142518B1 (de) 2012-05-02
KR100902145B1 (ko) 2009-06-10
CN101679312A (zh) 2010-03-24
US20100120803A1 (en) 2010-05-13
JP5330377B2 (ja) 2013-10-30
WO2008136631A1 (en) 2008-11-13
EP2142518A4 (de) 2010-08-04
KR20080099108A (ko) 2008-11-12
JP2010526133A (ja) 2010-07-29

Similar Documents

Publication Publication Date Title
TW200800968A (en) Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
NZ577916A (en) Cyclopamine analogs
MX2010009646A (es) Agentes terapeuticos antivirales.
SG178952A1 (en) Chemical compounds
GEP20146125B (en) Aminopyrimidines as syk inhibitors
WO2007135527A3 (en) Benzimidazolyl compounds
MX363189B (es) Productos químicos, composiciones y métodos para tratamiento y prevención de infecciones de virus orthopox y enfermedades asociadas.
MX2010004491A (es) Derivados de piridina y pirazina utiles en el tratamiento de trastornos proliferativos celulares.
MY151986A (en) Adamantyl diamide derivatives and uses of same
IL204437A (en) History of aryl cyclic profile and their use
TW200714604A (en) Substituted heterocycles and the uses thereof
BRPI0717266A2 (pt) Derivados de oxindol
TW200942535A (en) Novel compounds as cannabinoid receptor ligands
CL2008002243A1 (es) Compuestos derivados de 2-pirazolamino-1,3,5-triazina, inhibidores de kinasa jak; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento del cancer.
HK1217294A1 (zh) 4'-氟-2'-甲基取代的核苷衍生物
MX2010005649A (es) Compuestos novedosos como ligandos del receptor canabinoide y sus usos.
MY153763A (en) Quinazolinedione derivatives, preparation thereof and therapeutic uses thereof
TNSN08370A1 (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
AU2007249926A8 (en) Monocyclic heteroaryl compounds
WO2008104473A3 (en) Pyrazolopyriidine derivatives and their use as kinase inhibitors
ATE521609T1 (de) Aminothiazolylpyrimidinderivate und ihre verwendung bei der behandlung von krebs
TR201901977T4 (tr) Cxcr3 reseptörü modülatörleri olarak (r)-2-metil-piperazin türevleri.
ATE556062T1 (de) 3,4-dihydrochinazolinderivate
TW200800993A (en) Organic compounds
ATE481972T1 (de) Chinazolinon-derivate als vanilloid-antagonisten